Loading...
XSWX
EVE
Market cap19mUSD
Jul 10, Last price  
2.21CHF
1D
2.31%
1Q
165.63%
Jan 2017
-98.56%
IPO
-99.92%
Name

Evolva Holding SA

Chart & Performance

D1W1MN
XSWX:EVE chart
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
18.04%
Rev. gr., 5y
1.11%
Revenues
0k
273,560164,510424,40418,927,00018,629,00011,080,0007,014,0008,706,0009,283,0009,400,0008,748,0006,847,0008,933,00011,596,0007,541,0009,878,00015,539,0009,438,00000
Net income
-653k
L
-72,531,000-59,120,000-8,662,000-9,609,000-23,299,000-22,452,000-16,005,000-15,732,000-21,353,000-31,892,000-35,971,000-38,977,000-29,214,000-21,639,000-29,870,000-41,266,000-43,366,000-105,229,0001,044,000-652,700
CFO
-1m
L-53.14%
-53,947,330-59,087,490-44,535,168-5,933,657-15,831,343-17,402,435-13,445,766-12,523,800-19,943,700-31,729,200-33,852,300-35,572,900-23,607,000-14,160,500-23,362,700-29,789,200-18,880,700-9,254,500-2,439,300-1,143,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Evolva Holding SA is a Swiss-headquartered firm, established in 2004, that operates internationally, including in the United States. The company focuses on identifying, scientifically exploring, advancing, and bringing to market natural, bio-based ingredients. These innovative compounds are utilized across a range of sectors, such as the creation of flavors and fragrances, health and wellness products, and protective health solutions. Evolva's diverse product portfolio includes: Veri-te Resveratrol: A plant-derived polyphenol naturally present in grapes, peanuts, cranberries, and other berries. L-Arabinose: A flavoring agent essential for the Maillard reaction. Valencene: An aromatic component found in citrus fruits and derived from citrus. Nootkatone: A grapefruit aroma ingredient produced through the biochemical oxidation of valencene. Vanillin: The principal aromatic constituent extracted from vanilla beans.
URL
https://www.evolva.com/
IPO date
May 04, 2005
Employees
50
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT